Retour aux projets

41554.1 IP-LS

41554.1 IP-LS

Résumé

Targeted Liposome in Cardiovascular Disease (TARGET-CVD)

Textes supplémentaires

Abstract

Cardiovascular disease is an important cause of morbidity and mortality with underlying causes occur locally. Local release of potent molecules is an unmet medical need providing enhanced effectiveness with increased safety. Novel hard shelled liposomes release molecules at sites of disease.

Participants

Andreas Zumbühl

Wirtschaftspartner

andreas.zum@icloud.com

Acthera Therapeutics AG CHE-328.740.542 Andreas Zumbühl Mattenstrasse 22 4058 Basel BS CH

Alexander Akhmedov

Kontaktperson

alexander.akhmedov@uzh.ch

Universität Zürich Center for Molecular Cardiology Alexander Akhmedov Wagistrasse 12 8952 Schlieren ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2020-04-30
Date de fin
2021-04-30
Coûts totaux approuvés
CHF 252001.85
Section
60 Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • B007 Medicine (human and vertebrates) 100.0%